从外围衍生的调节性T细胞以非冗余的方式促进瘤介导的免疫抑制
Md Moazzem Hossain1, Paul King1, Justin Hackett2
1Department of Biochemistry, Microbiology and Immunology, Wayne State University Medical School, Detroit, MI 48201.
概括
瘤细胞产生调节性T细胞 (Tregs),抑制免疫力. 阻止这些外围Tregs可以防止癌症生长而不会引起自身免疫,从而提供了一种新的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 瘤诱导的免疫抑制是有效的癌症治疗的主要障碍.
- 调节性T细胞 (Tregs) 是这种抑制的关键媒介,但由于自身免疫的风险,它们的系统性消除受到阻碍.
- 外围衍生Tregs (pTregs) 是Tregs的一个特定子集,涉及到瘤免疫逃避.
研究的目的:
- 调查外围衍生Tregs (pTregs) 在瘤进展中的作用.
- 确定选择性消除pTregs是否可以在不诱导自身免疫的情况下预防或延迟恶性瘤.
- 通过了解瘤介导免疫抑制来确定癌症治疗的新型治疗点.
主要方法:
- 利用小鼠模型对T细胞中的克鲁佩尔样因子2 (Klf2) 转录因子进行有针对性的删除,以特别阻止pTreg生成.
- 在患有癌症的小鼠中进行KLF2表达,以诱导瘤特异性pTreg形成.
- 在黑色素瘤和前列腺癌模型中分析了免疫细胞种群,T细胞效应器功能,瘤透和pTreg缺乏和对照小鼠的瘤生长.
主要成果:
- 在临床前模型中,消除pTregs显著延迟或预防瘤恶性病变.
- 缺乏pTreg的小鼠表现出增强的抗瘤免疫力,包括改善T细胞透到瘤中,减少T细胞耗尽.
- 阻断pTreg生成限制了与瘤相关的骨髓质衍生抑制细胞的发展,并保持了循环效应T细胞.
- 特定于瘤的pTreg被确定为早期癌症进展的关键因损害T细胞效应因子活性.
结论:
- 选择性向瘤特异性pTregs为癌症治疗提供了一个有希望的策略.
- 破坏pTreg生成可以增强抗瘤免疫力并延迟恶性瘤,而不会引起系统性自身免疫力.
- 这些发现强调了pTregs作为开发针对各种癌症的新型免疫疗法的关键目标.
更多相关视频
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
7.5K
09:01Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
306
相关概念视频
01:27Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
01:24T Cell Types and Functions
963
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
963
01:40Cell-mediated Immune Responses
67.9K
Overview
67.9K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
01:27Cytotoxic T Cells-mediated Immune Response
861
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
861